文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一种与活性氧物种相关的特征可预测脑肿瘤的预后和免疫抑制微环境。

A reactive oxygen species-related signature predicts the prognosis and immunosuppressive microenvironment in gliomas.

机构信息

Department of Radiotherapy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

Redox Rep. 2024 Dec;29(1):2433396. doi: 10.1080/13510002.2024.2433396. Epub 2024 Nov 28.


DOI:10.1080/13510002.2024.2433396
PMID:39607823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11610310/
Abstract

OBJECTIVE: Intracellular redox homeostasis is crucial for a series of physiological processes. Reactive oxygen species (ROS) play important roles in redox processes. ROS can maintain cell reproduction and survival at moderate levels while promoting the initiation and progression of tumors at high levels. METHODS: Based on a comprehensive analysis of ROS-related gene expression profiles, we established a gene signature associated with ROS to explore its influence on prognosis and immune microenvironment in gliomas. RESULTS: The ROS-related gene expression profile dichotomized patients into two groups with different clinicopathological features and prognoses. A 19-gene ROS-related signature was used to robustly predict prognosis in both training and validation datasets. Functional analysis indicated an association between ROS levels and the immune microenvironment. The expression of immune checkpoints and M2-type markers was upregulated in the high-risk group, which suggested the immunosuppressive function of ROS. CONCLUSION: ROS-related signature is an independent prognostic factor in gliomas and could potentially exert immunosuppressive effects on the tumor microenvironment.

摘要

目的:细胞内氧化还原稳态对一系列生理过程至关重要。活性氧(ROS)在氧化还原过程中发挥重要作用。ROS 可以在中等水平维持细胞繁殖和存活,而在高水平时促进肿瘤的发生和发展。

方法:基于对 ROS 相关基因表达谱的综合分析,我们建立了一个与 ROS 相关的基因特征,以探讨其对脑胶质瘤预后和免疫微环境的影响。

结果:ROS 相关基因表达谱将患者分为两组,具有不同的临床病理特征和预后。使用 19 个 ROS 相关基因的特征可以在训练和验证数据集中稳健地预测预后。功能分析表明 ROS 水平与免疫微环境之间存在关联。在高危组中,免疫检查点和 M2 型标志物的表达上调,提示 ROS 具有免疫抑制功能。

结论:ROS 相关特征是脑胶质瘤的一个独立预后因素,可能对肿瘤微环境产生免疫抑制作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/0208f03740e2/YRER_A_2433396_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/da4f3514de1e/YRER_A_2433396_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/787391ca976b/YRER_A_2433396_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/c5daf2ff365a/YRER_A_2433396_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/8d53500314db/YRER_A_2433396_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/0208f03740e2/YRER_A_2433396_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/da4f3514de1e/YRER_A_2433396_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/787391ca976b/YRER_A_2433396_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/c5daf2ff365a/YRER_A_2433396_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/8d53500314db/YRER_A_2433396_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6edb/11610310/0208f03740e2/YRER_A_2433396_F0005_OC.jpg

相似文献

[1]
A reactive oxygen species-related signature predicts the prognosis and immunosuppressive microenvironment in gliomas.

Redox Rep. 2024-12

[2]
Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.

Oncotarget. 2016-11-8

[3]
Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.

Biosci Rep. 2021-12-22

[4]
Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma.

Clin Transl Oncol. 2025-5

[5]
The prognostic model of low-grade glioma based on m6A-associated immune genes and functional study of FBXO4 in the tumor microenvironment.

PeerJ. 2025-3-21

[6]
High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients.

Front Immunol. 2024

[7]
Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas.

Sci Rep. 2024-7-9

[8]
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.

J Cell Physiol. 2021-1

[9]
The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis.

Hum Genomics. 2024-7-2

[10]
MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.

Dis Markers. 2021

本文引用的文献

[1]
FeO-Coated CNTs-Gum Arabic Nano-Hybrid Composites Exhibit Enhanced Anti-Leukemia Potency Against AML Cells via ROS-Mediated Signaling.

Int J Nanomedicine. 2024

[2]
Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death.

Biochim Biophys Acta Rev Cancer. 2024-9

[3]
Targeting ROS in cancer: rationale and strategies.

Nat Rev Drug Discov. 2024-8

[4]
17β-estradiol Inhibits Oxidative Stress-Induced Apoptosis in Endometrial Cancer Cells by Promoting FOXM1 Expression.

Cell Biochem Biophys. 2024-6

[5]
Microglia and macrophage metabolism: a regulator of cerebral gliomas.

Cell Biosci. 2024-4-17

[6]
ROS regulation in gliomas: implications for treatment strategies.

Front Immunol. 2023

[7]
Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations.

J Clin Invest. 2023-11-16

[8]
Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity.

Cell Death Dis. 2023-10-13

[9]
Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.

Front Immunol. 2023

[10]
Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway.

Pharmaceuticals (Basel). 2023-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索